Navigation
Excelsio Media by Nelson Alarcón - alarcónnelson

U.S. FDA approves experimental Alzheimer's drug

U.S. FDA approves experimental Alzheimer's drug
The U.S. Food and Drug Administration approved the Alzheimer's drug lecanemab developed by Eisai and Biogen for patients in the earliest stages of the mind-wasting disease.


Share

Excelsio Media

EXCELSIO Media, is an independent source of news and information.

Post A Comment:

0 comments:

Leave a comment. Thanks!